SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001047469-17-002634
Filing Date
2017-04-14
Accepted
2017-04-14 14:16:19
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-4 a2231801zs-4.htm S-4 871278
2 EX-23.1 a2231801zex-23_1.htm EX-23.1 3003
3 G44098.JPG g44098.jpg GRAPHIC 8336
4 G922024.JPG g922024.jpg GRAPHIC 33092
5 G4873.JPG g4873.jpg GRAPHIC 25393
  Complete submission text file 0001047469-17-002634.txt   967673
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 6108166640
Nabriva Therapeutics Plc (Filer) CIK: 0001703287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-217315 | Film No.: 17762699